Ep0065 237 — Durham, North Carolina

Ep0065 237 is a clinical research site located in Durham, North Carolina, United States 27710.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Ep0065 237 has participated in 1 clinical trials.

Therapeutic areas: Epilepsy.

Sponsors: UCB Biopharma S.P.R.L..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Durham

Browse all research sites in North Carolina · View every site in Durham

• Duke University Medical Center- Duke Integrative Medicine
• Duke University Clinic
• The Brain Tumor Center at Duke, Duke University Medical Center
• Duke University Eye Center; Vitreoretinal
• Duke University - Duke Children's Hospital & Health Center
• Durham Veterans Administration
• Duke University Medical Denter
• Duke University Medical Center / Civitan Building
• Duke University Medical Center, Children's Health Center
• Duke University School of Medicine - Dept. of Ophthalmology
• Duke University Medical Center, Duke Infectious Diseases
• Duke University Medical Center /ID# 214435

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ep0065 237?

Ep0065 237 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ep0065 237 conducted?

Ep0065 237 has 1 clinical trials on record. Their work covers Epilepsy.

Is Ep0065 237 accredited by Crixeo Clinical Trials?

Ep0065 237 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ep0065 237?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.